Drug profile · INN
polyethylene glycol 3350
POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL
polyethylene glycol 3350 (POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL) is a osmotic laxative. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — polyethylene glycol 3350
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 7
- Data quality
- 0.89
Quick answer
polyethylene glycol 3350 (POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL) is a osmotic laxative. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Osmotic laxative
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is polyethylene glycol 3350?
polyethylene glycol 3350 (POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL) is a osmotic laxative. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for polyethylene glycol 3350?
POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; BISACODYL is a marketed brand name for polyethylene glycol 3350. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of polyethylene glycol 3350?
polyethylene glycol 3350 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.